A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

The requested reference [747ba5f5bcc3b39520564cab92bf0f15f05bf603] no longer exists in our database. It has been replaced by the current reference: [1111b361c1952535516ae4e522ca686a8c66606a]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The aim of the study is to compare the efficacy and safety of two JY09 doses versus dulaglutide as add-on therapy to metformin in participants with type 2 diabetes mellitus (T2DM)
Epistemonikos ID: c443f80d0320aa271c84fbd6a65f29106c8572db
First added on: May 15, 2024